MarketInOut Stock Screener Log In | Sign Up

Jenburkt Pharmaceuticals Ltd

Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/28/2026 15:52
Jenburkt Pharmaceuticals Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Market Capitalization3,865.83 mln
Float2.15 mln

EPS

74.47
Exceptional

P / E

11.76
Fair value

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.24
Borderline

Relative Strength

49 / 100
In line with market

Debt / Equity

0.01
Debt-free

Business Description

Founded in 1985 and headquartered in Mumbai, Jenburkt Pharmaceuticals Limited develops and sells a wide range of medicines across India and several international markets. The company's product portfolio covers many common health needs, including pain relief, diabetes management, infections, digestive health, and nutritional support, sold under dozens of proprietary brand names. Jenburkt supplies both private healthcare providers and large public institutions, including government hospitals and state-run enterprises.

Key Fundamentals

EPS74.47
P/E11.76
ROE17.85
RPS382
ROIC16.57
ROA15.60
Interest Cover78.34
EBITDA, mln466
EV / EBITDA7.27
EV / EBIT7.78
Revenue, mln1,687
EV / Revenue2.01

Quote Details

Last 875.95
Change 0.5 (0.06%)
Open 888.90
Volume 1,587
Turnover 1,390,133
Average Volume 2,371.1

Financial Ratios

Pre-Tax Profit Margin26
Current Ratio4.11
Price / Book2.00
Price / Tangible Book2.00
Price / Free Cash Flow24.21
Debt / Equity0.01
Price / Sales2.34
PEG Ratio0.70

Financial Strength

Altman Z-Score10.9
Piotroski F-Score 5 / 9
Beneish M-Score-2.24
Price to Intrinsic Value1.08
Price to Lynch Fair Value0.87
Price to Graham Number0.97
Shiller PE Ratio14.74

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -1.77% 46 / 100   
1 Month -7.6% 48 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog